FIELD: medicine.
SUBSTANCE: invention refers to medicine, more specifically to pharmacology, cell technologies and regenerative medicine. Task solved by this invention, is increasing of effective agents range stimulating tissue regeneration. Assigned task is solved by using as tissue regeneration stimulating agents, of pharmacological substances having direct action on PI3K-, PKB-, PKC-, NF-κB-, MAPK-, JAK/STAT, cAMP-, PKA/CREB-mediated signaling in progenitor cells.
EFFECT: proposed agents allow to efficiently stimulate regeneration of tissues impaired by pathological process, due to activation of resident (regional) progenitor cells functions by effect on intracellular signal transduction.
8 cl, 24 tbl, 7 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR STIMULATING GRANULOCYTE COLONY STIMULATING FACTOR PRODUCTION BY BONE MARROW CELLS IN VITRO | 2017 |
|
RU2665818C1 |
METHOD FOR STIMULATING PRODUCTION OF ERYTHROPOIETIN IN A CELL CULTURE in vitro | 2015 |
|
RU2589288C1 |
HEMOPROTECTIVE AGENT | 2019 |
|
RU2725135C1 |
METHOD OF INDUCING TARGETED DIFFERENTIATION OF MULTIPOTENT PROGENITOR CELLS OF PANCREAS IN INSULIN-PRODUCING BETA CELLS DURING DIABETES | 2014 |
|
RU2579997C2 |
HEMOSTIMULATING AGENT | 1994 |
|
RU2088249C1 |
METHOD FOR STIMULATING PRODUCTION OF ERYTHROPOETIN BY BONE MARROW CELLS IN VITRO | 2016 |
|
RU2628882C1 |
PREPARATION, POSSESSING REGENERATIVE ACTIVITY | 2012 |
|
RU2475260C1 |
AGENT STIMULATING MESENCHYMAL PROGENITOR CELL FUNCTIONS IN VITRO | 2018 |
|
RU2686718C1 |
MEDICATION, POSSESSING WOUND-HEALING ACTIVITY | 2012 |
|
RU2481836C1 |
EXPERIMENTAL TOXIC CHRONIC HEPATITIS TREATMENT METHOD | 2009 |
|
RU2392000C1 |
Authors
Dates
2016-10-10—Published
2013-12-20—Filed